91 Results for "

Antituberculosis activity

" in MedChemExpress (MCE) Product Catalog:
Products (91)

91 Results for "Antituberculosis activity" in MCE Product Catalog:

Cat. No.: HY-N19992
Synonyms: Rabdosia serra extract
Category:  

Extract

Target:  

Bacterial

Isodon serra extract (Rabdosia serra extract) is an extract of Isodon serra (Maxim.) Hara, which has antitumor, anti-angiogenic, analgesic, anti-tuberculosis, anti-inflammatory, antibacterial and anti-ischemic activities.
loading...
    loading...
Cat. No.: HY-184411
CAS No.: 3104768-44-4
Target:  

Bacterial

Research Areas:  

Infection

TB-212 is a potent, orally active anti-tuberculosis agent. TB-212 exhibits activity against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains, with favorable safety profiles. TB-212 is applicable to the research of tuberculosis .
loading...
    loading...
Cat. No.: HY-N9229
CAS No.: 1612239-23-2
Myricadenin A is an iNOS inhibitor, capable of effectively inhibiting the production of NO (EC₅₀ = 18.1 μM). Myricadenin A has moderate ABTS free radical scavenging activity (SC₅₀ = 175.4 μM) and relatively weak anti-tuberculosis activity (MIC = 80.0 μg/mL). Myricadenin A can be used in inflammation-related research .
loading...
    loading...
Cat. No.: HY-W013677S1
CAS No.: 285977-82-4
4-Fluorobenzoic acid- 13C,d4 is the 13C- and deuterium labeled 4-Fluorobenzoic acid (HY-W013677). 4-Fluorobenzoic acid is a drug intermediate that can be used to synthesize a series of hydrazone derivatives with antituberculosis activity and Schiff bases with DPPH radical scavenging activity .
loading...
    loading...
Cat. No.: HY-173205
Target:  

Bacterial

Research Areas:  

Infection

Antimycobacterial agent - 11 (Compound QM7) is a bacteriostatic agent with anti-tuberculosis activity. Its minimum inhibitory concentration (MIC) against Mycobacterium tuberculosis (Mtb) is 5.58 μg/mL. Antimycobacterial agent - 11 can be used in the research of the anti - infection field, especially in the field of tuberculosis .
loading...
    loading...
Cat. No.: HY-129819
CAS No.: 1333170-15-2
Target:  

Bacterial

Research Areas:  

Infection

(Rac)-DNDI-8219 is an antituberculosis compound with potent anti-leishmanial activity. (Rac)-DNDI-8219 demonstrated superior efficacy in the Leishmania donovani mouse model. (Rac)-DNDI-8219 showed promising activity in the Leishmania infantum hamster model. (Rac)-DNDI-8219 candidate compound R-6 provided excellent oral efficacy in the same hamster model .
loading...
    loading...
Cat. No.: HY-134940S1
Synonyms: OPC-167832-d4
Quabodepistat-d4 (OPC-167832-d4) is the deuterium labeled Quabodepistat (HY-134940). Quabodepistat (OPC-167832) is a potent and orally active dprE1 inhibitor with an IC50 of 0.258 μM. Quabodepistat has antituberculosis activity and can be used for the research of tuberculosis caused by Mycobacterium tuberculosis .
loading...
    loading...
Cat. No.: HY-187375
Target:  

Bacterial

Research Areas:  

Infection Inflammation/Immunology

DL25 is a fungicide with an IC50 of 5.0 μg/mL against Mycobacterium tuberculosis DHQS. DL25 binds with high affinity to mycobacterial targets LysA, LpdA and SecA1. DL25 exhibits broad-spectrum anti-mycobacterial activity against multiple mycobacterial species and shows partial synergy with established anti-tuberculosis drugs. DL25 can be used in studies related to tuberculosis .
loading...
    loading...
Cat. No.: HY-183688
CAS No.: 3104354-58-4
Research Areas:  

Infection

MptpB-IN-3 is a selective inhibitor of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) with an IC50 of 0.19 μM. MptpB-IN-3 blocks MptpB-mediated inhibition of the macrophage MAPK pathway and restores the phosphorylation levels of Erk1/2 and p38. MptpB-IN-3 exhibits direct anti-tuberculosis activity against Mycobacterium tuberculosis and reduces the Mycobacterium tuberculosis load in mouse macrophages. MptpB-IN-3 can be used for tuberculosis research .
loading...
    loading...
Cat. No.: HY-201256
CAS No.: 301312-49-2
Target:  

Bacterial MDM-2/p53

Research Areas:  

Infection

UCI-14 is a gltA1/lprQ modulator with in vitro anti-tuberculosis activity against drug-sensitive and multidrug-resistant mycobacteria. UCI-14 upregulates the expression of genes encoding citrate synthase I, downregulates the expression of genes encoding conserved mycobacterial lipoprotein, and alters the carbon metabolism of mycobacteria. UCI-14 reactivates the expression of wild-type p53 target genes in p53-mutated cells. UCI-14 can be used in the research of tuberculosis and cancer .
loading...
    loading...
Cat. No.: HY-179529
Target:  

EGFR Bacterial

Research Areas:  

Infection Cancer

EGFR/InhA-IN-1 (Compound 15) is an inhibitor of the anti-cancer target EGFR tyrosine kinase (1M17) (Ki = 0.05 μM) and the anti-tuberculosis target InhA enzyme (1OUZ) (Ki = 0.02 μM). EGFR/InhA-IN-1 exhibits anti-proliferative activity against A549 cells, with an IC50 of 10.38 μM. EGFR/InhA-IN-1 has inhibitory activity against Mycobacterium tuberculosis H37Rv, with a MIC of 6.25 μM. EGFR/InhA-IN-1 can be used for research on non-small cell lung cancer and Mycobacterium tuberculosis infection .
loading...
    loading...